When a continuous line of rabbit kidney cells (RK-13) was exposed to polyriboinosinic acid polyribocytidilic acid [poly(rI) poly(rC) ], the cells became resistant to the replication of a ribonucleic acid (RNA) virus, vesicular stomatitis (VSV), but remained susceptible to the replication of two deoxyribonucleic acid (DNA) viruses, pseudorabies and vaccinia. These differences were identical to previous findings with RK-13 cells pretreated with exogenous rabbit interferon. Confirmation is thereby provided that RK-13 cells are deficient in the synthesis of resistance factors active against the DNA viruses tested and that there are separate resistance factors for RNA and DNA viruses in RK-13 cells. The resistance against VSV which developed in RK-13 cells exposed to poly(rI) -poly-(rC) could be significantly reversed by prior infection with infective vaccinia virus but not by vaccinia inactivated by ultraviolet irradiation or heat.
We reported previously (3) that although two deoxyribonucleic acid (DNA) viruses, pseudorabies (PsRV) and vaccinia, are as susceptible as a ribonucleic acid (RNA) virus, vesicular stomatitis virus (VSV), to interferon when tested in chicken or mouse cells, they are refractory to inhibition in interferon-treated primary rabbit kidney cells and in a continuous line (RK-13) of rabbit kidney cells. These results provided evidence (i) for the possible existence of separate and distinct resistance factors for RNA and DNA viruses and (ii) for the possibility that rabbit kidney cell cultures are deficient in the synthesis of sufficient resistance factors to inhibit the DNA viruses tested.
In the case of sequential infection of interferon-treated RK-13 cells with vaccinia and VSV, it was found that not only was vaccinia replication refractory to inhibition by interferon, but also that prior infection with vaccinia was able to reverse partially the effect of the inhibitor on the replication of the VSV used for superinfection (3) .
This paper reports further experiments carried out by using the synthetic double-stranded polyribonucleotide, polyriboinosic acid polyribocytidilic acid [poly(rI) -poly(rC)], as an inducer of endogenous resistance in RK-13 cells.
The use of this inducer would (i) test the possibility that the exogenous rabbit interferon used in our previous study (3) was deficient in its ability to induce the synthesis of resistance factors for DNA viruses or that RK-13 cells may be defective in their response to or reaction with exogenous interferon, and (ii) determine whether the endogenous resistance to VSV developed in RK-13 cells exposed to poly(rI) -poly-(rC) could be partially or fully reversed by infection with vaccinia virus.
MATERIALS AND METHODS Cells. RK-13, obtained through the courtesy of Kurt Paucker (Medical College of Pennsylvania, Philadelphia), was grown in Eagle minimal essential medium with 10% calf serum. Primary chicken embryo (CE) cell cultures were propagated and maintained in Eagle medium plus 4% calf serum as described in detail elsewhere (2) .
Viruses. The Indiana strain of VSV was propagated in L cells as described earlier (2) . PsRV 
RESULTS
Replication of RNA and DNA viruses in RK-13 cells pretreated with poly(rI) -poly-(rC). Yield reduction experiments were carried out as follows. RK-13 cell monolayers (2.5 x 106 cells) were exposed for 1 h to different amounts of poly(rI) poly(rC) as described above. After incubation for 18 h at 37 C, the culture fluid was collected to test for induced interferon activity. The monolayers were infected with VSV, PsRV, or vaccinia at an input multiplicity of infection (MOI) of 10; after an additional incubation of 18 h, the cells and fluids were harvested together, subjected to sonic oscillation to release cell-associated virus, and assayed for infectivity. Significant inhibition of VSV yield occurred in cultures which had been pretreated with 100 or 10 gg of poly(rI) poly(rC); in contrast, similar pretreatment produced no significant inhibition of PsRV or vaccinia yields ( Table 1 ). The inhibition of VSV yield by poly(rI) .poly(rC) was correlated with the production of interferon by the inducer ( (3) with RK-13 cells doubly infected with vaccinia and VSV showed that vaccinia replication was refractory to inhibition by interferon and that prior infection with vaccinia was able to reverse significantly the effect of interferon on the replication of VSV used for superinfection. Since VSV replication was inhibited in RK-13 cells pretreated by poly(rI) -poly(rC) but vaccinia replication was not, it was of interest to determine if the endogenous resistance to VSV induced by poly(rI) poly(rC) could be reversed by infection with vaccinia, as was the case with exogenous, added interferon.
RK-13 cell monolayers were treated with poly(rI) .poly(rC) (100 ,ug/culture) as described above. After incubation for 18 h at 37 C, the culture fluid was removed (to be tested for interferon activity) and groups of cultures were infected singly with either vaccinia or VSV. In the case of doubly infected cultures, VSV was added simultaneously with vaccinia or 2, 3, or 5 h after infection with vaccinia. Also included in this experiment were groups of cell cultures pretreated with 1,000 U of rabbit interferon, instead of poly(rI) .poly(rC), and then either singly or doubly infected as described above. In the case of double infection of interferon-treated RK-13 cells, VSV was added 2 h after vaccinia infection, since maximal reversal by vaccinia of the inhibitory effects of interferon was seen under these conditions (3). Virus yields from cells and infected fluids harvested 18 h after infection were assayed as described above.
In agreement with results previously reported (3), the data in Table 2 show that VSV replication was inhibited in RK-13 cells pretreated with interferon (group 4), whereas vaccinia replication was not affected under the same conditions (group 5). Double infection of control cultures with vaccinia and VSV produced a 1 log facilitation of VSV replication (group 3), as observed previously (3). In addition, prior infection of interferon-treated cells with vaccinia significantly reversed the inhibitory action of interferon on VSV (group 6), resulting in a 430-fold increase in VSV yield over the yield obtained in control cultures (group 4) which showed maximal inhibition of VSV.
The results obtained with poly(rI) poly(rC) ( Table 2 ) completely duplicated those obtained by using pretreatment with interferon. In RK-13 cells pretreated with 100 jsg of the synthetic polyribonucleotide, VSV yield was reduced by 4.2 log (group 7), whereas vaccinia replication was inhibited by only 0.5 log (group 8). However, when cells pretreated with poly-(rI) -poly(rC) were infected with vaccinia and then infected with VSV either simultaneously (group 9) or at various times after vaccinia infection (groups 10 to 12), there was a 710-to 5,710-fold increase in VSV yield compared to VSV yield from poly(rI) poly(rC)-treated RK-13 cell cultures infected with VSV alone (group 7). These results indicated that vaccinia infection is capable of significantly reversing the antiviral resistance against VSV replication developed after exposure of RK-13 cells to either rabbit interferon or the synthetic polyribonucleotide, poly(rI) -poly(rC).
Additional experiments were conducted to determine the effect of varying amounts of poly(rI) poly(rC) on viral replication in single and double infections of RK-13 cells with vaccinia and VSV. RK-13 cell cultures (2.5 x 106 cells) were exposed, as described above, to amounts of poly(rI) .poly(rC) ranging from 0.1 to 100 Ag per culture. After incubation for 18 h at 37 C, culture fluids were collected (to be assayed for interferon activity) and the cells were infected in the usual manner singly with vaccinia and VSV or simultaneously with the two viruses. After 18 h of additional incubation, total virus content of the cultures was deter- Table 3 also show (i) that vaccinia replication was not significantly inhibited by the highest amount of poly(rI) .poly(rC) used and (ii) that maximal inhibition of VSV by poly(rI) .poly(rC) was correlated with the induction of interferon in cultures pretreated with the synthetic polyribonucleotide. The amount of interferon produced in RK-13 cells by a given dose of poly(rI).
poly(rC) varied somewhat from experiment to experiment (see Tables) . Infective and noninfective vaccinia virus; effect on enhancement of VSV replication and on reversal of antiviral resistance in RK-13 cells. An experiment was carried out to establish whether noninfective vaccinia virus was capable of enhancing VSV yields or reversing the antiviral resistance developed in RK-13 cells pretreated with poly(rI) -poly(rC). Noninfective vaccinia was obtained by exposing the virus (3.4 x 107 PFU/ml) to ultraviolet (UV) irradiation for 5 min by a method previously described (2) . This irradiation resulted in a complete loss of infectivity for CE cell cultures. RK-13 cells were pretreated with 100 Mg of poly(rI) .poly(rC) in the usual manner and then infected singly or doubly with vaccinia and VSV. Total virus replication in each group of cultures was determined as usual 18 h after infection and the results are tabulated in Table  4 . As observed in previous experiments, double infection of untreated control cultures with infective vaccinia and VSV resulted in about a 1 log increase in VSV yield (group 4). In contrast, with UV-irradiated vaccinia virus, VSV yield (rC) what we had previously found in RK-13 cells pretreated with rabbit interferon has several important implications. First, the resistance patterns against RNA and DNA viruses developed in cells exposed to poly(rI) poly(rC), which parallel those in cells exposed to rabbit interferon, discount defectiveness of rabbit interferon or its reaction with RK-13 cells as the reason for this finding. Instead, the results point to some deficiency in the ability of RK-13 cells to produce resistance factors against the DNA viruses tested. As with cells pretreated with rabbit interferon, the double infections carried out with vaccinia and VSV in cells pretreated with poly(rI) * poly(rC) demonstrate that, in the same cell, one virus (vaccinia) can be refractory to interferon and a second virus (VSV) can be susceptible.
Experiments utilizing mixed infections with vaccinia and VSV in poly(rI) .poly(rC) -treated RK-13 cells produced results similar to those obtained when rabbit interferon was employed (3) . Not only was vaccinia virus refractory to inhibition in cells pretreated with the synthetic polyribonucleotide, but the DNA virus was able VOL. 7, 1973 on October 15, 2017 by guest http://iai.asm.org/
